Gender: Any

Study Description:
This study is testing an investigational injectable medication compared to a placebo for the treatment of Cirrhosis caused by NASH. Participants will receive the study medication or placebo for approximately 6.5 months. Additional procedures include Magnetic Resonance Imaging (MRIs), FibroScans, physical examinations and laboratory assessments. Total participation will last approximately 10 months and would include 10 doctor’s visits throughout the study. Eligibility for the study will be determined by the study doctor following two in-person screening visits to the clinic. Trial-related procedures and study medication will be provided at no cost.

Qualifications/Highest DQs:
- Must have been told by a physician that you have cirrhosis of the liver and confirmed by a liver biopsy

PROOF REQUIRED

Mailer Access Key https://www.affiliateaccesskey.com/m-dzkm-s96-5230e15029858f461132ce37a5ab553d
Optout Link https://www.twonailhall.com/o-dzkm-s96-d848f0c3573bfa77a29aba97c5ee2b94